Patient demographics and postoperative complications
Parameters | Group | P value | |
Novel group | Traditional group | ||
No of patients | 145 | 230 | |
Age (x±s,years) | 44.23±10.45 | 44.59±10.75 | 0.835 |
Male (n (%)) | 69 (47.59%) | 110 (47.83%) | 0.964 |
Surgical side (right, n (%)) | 67 (46.21%) | 108 (46.96%) | 0.887 |
Clinical presentation (n (%)) | 0.511 | ||
Ischaemic type | 84 (57.93%) | 134 (58.26%) | |
Haemorrhagic type | 43 (29.66%) | 59 (25.65%) | |
Asymptomatic type | 18 (12.41%) | 37 (16.09%) | |
Risk factors (n (%)) | |||
Hypertension | 62 (42.76%) | 105 (45.65%) | 0.583 |
Diabetes mellitus | 38 (26.21%) | 54 (23.49%) | 0.550 |
Hyperlipidaemia | 32 (22.07%) | 55 (23.91%) | 0.680 |
Smoking | 47 (32.41%) | 66 (28.70%) | 0.445 |
Suzuki stage (n (%)) | 0.985 | ||
I | 0 (0%) | 0 (0%) | |
II | 10 (6.90%) | 18 (7.83%) | |
III | 65 (44.83%) | 104 (45.22%) | |
IV | 39 (26.89%) | 61 (26.52%) | |
V | 31 (21.38%) | 47 (20.43%) | |
VI | 0 (0%) | 0 (0%) | |
Postoperative complications (n (%)) | <0.001 | ||
Cerebral infarction | 2 (1.38%) | 15 (6.52%) | 0.009 |
Intracranial haemorrhage | 1 (0.69%) | 5 (2.17%) | 0.180 |
Hyperperfusion syndrome | 23 (15.86%) | 59 (24.35%) | 0.010 |
Neurological outcome (modified Rankin Scale) | 0.260 | ||
0 | 113 (77.93%) | 149 (64.78%) | |
1 | 21 (14.48%) | 42 (18.26%) | |
2 | 7 (4.83%) | 21 (9.13%) | |
3 | 2 (1.38%) | 10 (4.35%) | |
4 | 1 (0.69%) | 6 (2.61%) | |
5–6 | 1 (0.69%) | 2 (0.87%) |